"目前和新兴的阿尔茨海默病药物治疗方法:一种病理生理学的视角"
Aparajita Aparajita1, Unnati Jain1, Priyanka Srivastava1
1Department of Biosciences, Institute of Management Studies Ghaziabad 9(University Courses Campus), NH09, Adhyatmik Nagar, Ghaziabad, Uttar Pradesh, India.
Neuroscience
|December 11, 2024
概括
这项研究探讨了针对阿尔茨海默氏症等神经退行性疾病的药物开发,重点关注新型疗法和了解药物相互作用. 它审查了对于开发有效治疗认知缺陷的药理动力学研究至关重要.
科学领域:
- 神经科学和药理学 神经科学和药理学
- 药物开发和精准医学 药物开发和精准医学
背景情况:
- 慢性神经退行性疾病,如阿尔茨海默病 (AD) 呈现显著的认知缺陷.
- 目前的研究目标是神经退行机制,包括高酸化和粉样斑块.
研究的目的:
- 审查神经退行性疾病的目标和生物标志物的分析和实验研究.
- 探索治疗方法,包括人性化抗体和向药物开发.
- 检查药理动力学研究和药物相互作用,以优化治疗疗效.
主要方法:
- 在神经退行性疾病中认知缺陷的研究目标和生物标志物.
- 审查了当前的治疗策略,重点是药物开发和精准医学.
- 分析了药理动力学 (ADME) 研究和药物相互作用趋势.
主要成果:
- 确定了阿尔茨海默病和其他神经退行性疾病的关键目标和生物标志物.
- 突出了改性氨基酸,抗体和信号分子在治疗中的作用.
- 强调ADME研究和临床试验中药物相互作用分析的重要性.
结论:
- 针对神经退行性疾病的药物开发需要对目标,生物标志物和药理动力学有深入的了解.
- 新的治疗策略,包括基因工程药物,对未来的治疗有希望.
- 综合性药理动力学和药物相互作用研究对于安全有效的神经退行性疾病疗法至关重要.
相关概念视频
01:22Alzheimer's Disease: Treatment
163
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
163
01:26Alzheimer's Disease: Overview
447
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
447
01:28Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
96
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
96
01:15Parkinson's Disease: Overview
479
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
479
01:30Dementia
96
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
96